Search all trials

Find therapies in clinical trials near you – page 23

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Colorectal cancer metastatic+1

Not recruiting

Registered drugNo placebo

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tinzaparin Sodium

Contact Research Centre

Asthma+1

Not recruiting

Registered drug

Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

Registered drug

Spain

Participants:0–17 years
Substances:Budesonide

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drug

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Hormone receptor positive breast cancer+1

Not recruiting

Registered drugNo placebo

Study on Time Savings with Subcutaneous Pertuzumab and Trastuzumab for Patients with HER2-Positive Early Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

InvestigationalNo placebo

Study of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Patritumab Deruxtecan

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Frexalimab

Contact Research Centre

Prader-Willi syndrome

Not recruiting

Investigational

Study on the Safety and Effects of PBF-999 for Patients with Prader-Willi Syndrome

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Pbf-999

Contact Research Centre

Axial spondyloarthritis+1

Not recruiting

Investigational

Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Abt-494

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Urea cycle disorder+3

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Hhalpc

Contact Research Centre

Attention deficit hyperactivity disorder

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

Registered drug

Spain

Participants:0–17 years
Substances:Guanfacine

Contact Research Centre

Find therapies in clinical trials near you – page 23

293 trials match your criteria

Colorectal cancer metastatic+1

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Asthma+1

Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

Neoplasm malignant

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Gastroenteropancreatic neuroendocrine tumour disease

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Hormone receptor positive breast cancer+1

Study on Time Savings with Subcutaneous Pertuzumab and Trastuzumab for Patients with HER2-Positive Early Breast Cancer

Hormone receptor positive HER2 negative breast cancer

Study of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients

Systemic lupus erythematosus

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Prader-Willi syndrome

Study on the Safety and Effects of PBF-999 for Patients with Prader-Willi Syndrome

Axial spondyloarthritis+1

Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

Hormone-refractory prostate cancer+1

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Urea cycle disorder+3

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

Attention deficit hyperactivity disorder

Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.